Zeitschriftenartikel zum Thema „Chromodomain Helicase DNA binding 4 (CHD4)“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-47 Zeitschriftenartikel für die Forschung zum Thema "Chromodomain Helicase DNA binding 4 (CHD4)" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Kolla, Venkatadri, Koumudi Naraparaju, Tiangang Zhuang, Mayumi Higashi, Sriharsha Kolla, Gerd A. Blobel und Garrett M. Brodeur. „The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex“. Biochemical Journal 468, Nr. 2 (22.05.2015): 345–52. http://dx.doi.org/10.1042/bj20150030.
Der volle Inhalt der QuelleSillibourne, James Edward, Bénédicte Delaval, Sambra Redick, Manisha Sinha und Stephen John Doxsey. „Chromatin Remodeling Proteins Interact with Pericentrin to Regulate Centrosome Integrity“. Molecular Biology of the Cell 18, Nr. 9 (September 2007): 3667–80. http://dx.doi.org/10.1091/mbc.e06-07-0604.
Der volle Inhalt der QuelleLin, Shiaw-Yih, Jing Zhang und David J.H. Shih. „The Tale of CHD4 in DNA Damage Response and Chemotherapeutic Response“. Cancer Research and Cellular Therapeutics 3, Nr. 1 (08.07.2019): 01–03. http://dx.doi.org/10.31579/2640-1053/052.
Der volle Inhalt der QuelleHagman, James, Carissa Dege, Desiree Straign, Haiqun Jia, Kendra Walton, Kara Lukin, Hong Lei, Thomas Danhorn und Ann Feeney. „Chromodomain helicase DNA-binding 4 is required for proliferation, distal VH rearrangements and developmental progression of B cell progenitors (HEM1P.221)“. Journal of Immunology 194, Nr. 1_Supplement (01.05.2015): 50.4. http://dx.doi.org/10.4049/jimmunol.194.supp.50.4.
Der volle Inhalt der QuelleChohra, Ilyas, Subhajit Giri und Brigitte Malgrange. „Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1)“. International Journal of Molecular Sciences 24, Nr. 13 (23.06.2023): 10543. http://dx.doi.org/10.3390/ijms241310543.
Der volle Inhalt der QuelleLarsen, Dorthe Helena, Catherine Poinsignon, Thorkell Gudjonsson, Christoffel Dinant, Mark R. Payne, Flurina J. Hari, Jannie M. Rendtlew Danielsen et al. „The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage“. Journal of Cell Biology 190, Nr. 5 (30.08.2010): 731–40. http://dx.doi.org/10.1083/jcb.200912135.
Der volle Inhalt der QuelleHosokawa, Hiroyuki, Tomoaki Tanaka, Miki Kato, Yuuki Tamaki und Toshinori Nakayama. „Functionally distinct Gata3/Chd4 complexes coordinately establish Th2 cell identity. (P1340)“. Journal of Immunology 190, Nr. 1_Supplement (01.05.2013): 208.13. http://dx.doi.org/10.4049/jimmunol.190.supp.208.13.
Der volle Inhalt der QuelleArends, Tessa, Carissa Dege, Alexandra Bortnick, Thomas Danhorn, Jennifer R. Knapp, Haiqun Jia, Laura Harmacek et al. „CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis“. Proceedings of the National Academy of Sciences 116, Nr. 22 (13.05.2019): 10927–36. http://dx.doi.org/10.1073/pnas.1821301116.
Der volle Inhalt der QuelleO’Shaughnessy, Aoife, und Brian Hendrich. „CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now“. Biochemical Society Transactions 41, Nr. 3 (23.05.2013): 777–82. http://dx.doi.org/10.1042/bst20130027.
Der volle Inhalt der QuelleSmeenk, Godelieve, Wouter W. Wiegant, Hans Vrolijk, Aldo P. Solari, Albert Pastink und Haico van Attikum. „The NuRD chromatin–remodeling complex regulates signaling and repair of DNA damage“. Journal of Cell Biology 190, Nr. 5 (30.08.2010): 741–49. http://dx.doi.org/10.1083/jcb.201001048.
Der volle Inhalt der QuelleMusselman, Catherine A., Robyn E. Mansfield, Adam L. Garske, Foteini Davrazou, Ann H. Kwan, Samuel S. Oliver, Heather O'Leary, John M. Denu, Joel P. Mackay und Tatiana G. Kutateladze. „Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications“. Biochemical Journal 423, Nr. 2 (25.09.2009): 179–87. http://dx.doi.org/10.1042/bj20090870.
Der volle Inhalt der QuellePratheeshkumar, Poyil, Abdul K. Siraj, Sasidharan Padmaja Divya, Sandeep Kumar Parvathareddy, Khadija Alobaisi, Saif S. Al-Sobhi, Fouad Al-Dayel und Khawla S. Al-Kuraya. „CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells“. International Journal of Molecular Sciences 22, Nr. 2 (06.01.2021): 504. http://dx.doi.org/10.3390/ijms22020504.
Der volle Inhalt der QuelleHagman, James R., Tessa Arends, Curtis Laborda, Jennifer R. Knapp, Laura Harmacek und Brian P. O’Connor. „Chromodomain helicase DNA‐binding 4 (CHD4) regulates early B cell identity and V(D)J recombination*“. Immunological Reviews 305, Nr. 1 (20.12.2021): 29–42. http://dx.doi.org/10.1111/imr.13054.
Der volle Inhalt der QuelleQi, Wenjing, Hongyu Chen, Ting Xiao, Ruoxi Wang, Ting Li, Liping Han und Xianlu Zeng. „Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair“. Mutagenesis 31, Nr. 2 (06.11.2015): 193–203. http://dx.doi.org/10.1093/mutage/gev075.
Der volle Inhalt der QuelleOyama, Yoshiko, Shogo Shigeta, Hideki Tokunaga, Keita Tsuji, Masumi Ishibashi, Yusuke Shibuya, Muneaki Shimada, Jun Yasuda und Nobuo Yaegashi. „CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents“. PLOS ONE 16, Nr. 6 (23.06.2021): e0251079. http://dx.doi.org/10.1371/journal.pone.0251079.
Der volle Inhalt der QuelleHancock, Wayne W., Liqing Wang, Martina Minisini, Eros di Giorgio, Ivan Babic und Elmar Nurmemmedov. „Abstract 2655: Unexpected role of the NuRD component, Chd4, in Foxp3+ Treg cells and its relevance to tumor immunotherapy“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 2655. http://dx.doi.org/10.1158/1538-7445.am2024-2655.
Der volle Inhalt der QuelleDa Silva, Jorge Diogo, Natália Oliva-Teles, Nataliya Tkachenko, Joana Fino, Mariana Marques, Ana Maria Fortuna und Dezso David. „A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large Dup(2)(q14.3q21.1)“. Biomedicines 11, Nr. 1 (21.12.2022): 12. http://dx.doi.org/10.3390/biomedicines11010012.
Der volle Inhalt der QuelleYamada, Miki, Noriko Sato, Shinobu Ikeda, Tomio Arai, Motoji Sawabe, Seijiro Mori, Yoshiji Yamada, Masaaki Muramatsu und Masashi Tanaka. „Association of the chromodomain helicase DNA-binding protein 4 (CHD4) missense variation p.D140E with cancer: Potential interaction with smoking“. Genes, Chromosomes and Cancer 54, Nr. 2 (19.11.2014): 122–28. http://dx.doi.org/10.1002/gcc.22227.
Der volle Inhalt der QuelleDenson, Aspin, Matt Parker, WAGNER DIAS, Halyna Fedosyuk, Maria Villar-Lecumberri, Jeff Thompson, Harmony Saunders und Chad Slawson. „Abstract 1049 O-GlcNAc crosslinking of Chromodomain Helicase DNA Binding Protein 4 (CHD4) reveals novel functions for the Nucleosome Chromatin Remodeling Complex“. Journal of Biological Chemistry 300, Nr. 3 (März 2024): 106818. http://dx.doi.org/10.1016/j.jbc.2024.106818.
Der volle Inhalt der QuellePan, Mei-Ren, Hui-Ju Hsieh, Hui Dai, Wen-Chun Hung, Kaiyi Li, Guang Peng und Shiaw-Yih Lin. „Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment“. Journal of Biological Chemistry 287, Nr. 9 (04.01.2012): 6764–72. http://dx.doi.org/10.1074/jbc.m111.287037.
Der volle Inhalt der QuelleSingh, Ajeet P., Julie F. Foley, Mark Rubino, Michael C. Boyle, Arpit Tandon, Ruchir Shah und Trevor K. Archer. „Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest“. Molecular and Cellular Biology 36, Nr. 15 (16.05.2016): 1990–2010. http://dx.doi.org/10.1128/mcb.01101-15.
Der volle Inhalt der QuelleGuo, Tingting, Daofeng Wang, Jingjing Fang, Jinfeng Zhao, Shoujiang Yuan, Langtao Xiao und Xueyong Li. „Mutations in the Rice OsCHR4 Gene, Encoding a CHD3 Family Chromatin Remodeler, Induce Narrow and Rolled Leaves with Increased Cuticular Wax“. International Journal of Molecular Sciences 20, Nr. 10 (25.05.2019): 2567. http://dx.doi.org/10.3390/ijms20102567.
Der volle Inhalt der QuelleYuan, Chih-Chi, Xinyang Zhao, Laurence Florens, Selene K. Swanson, Michael P. Washburn und Nouria Hernandez. „CHD8 Associates with Human Staf and Contributes to Efficient U6 RNA Polymerase III Transcription“. Molecular and Cellular Biology 27, Nr. 24 (15.10.2007): 8729–38. http://dx.doi.org/10.1128/mcb.00846-07.
Der volle Inhalt der QuelleHeshmati, Yaser, Gözde Turköz, Aditya Harisankar, Sten Linnarsson, Marios Dimitriou, Indranil Sinha, Sören Lehmann, Hong Qian und Julian Walfridsson. „Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia“. Blood 128, Nr. 22 (02.12.2016): 1648. http://dx.doi.org/10.1182/blood.v128.22.1648.1648.
Der volle Inhalt der QuelleSilva, Ana P. G., Daniel P. Ryan, Yaron Galanty, Jason K. K. Low, Marylene Vandevenne, Stephen P. Jackson und Joel P. Mackay. „The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose)“. Journal of Biological Chemistry 291, Nr. 2 (12.11.2015): 924–38. http://dx.doi.org/10.1074/jbc.m115.683227.
Der volle Inhalt der QuelleSchulten, Hans-Juergen, und Sherin Bakhashab. „Meta-Analysis of Microarray Expression Studies on Metformin in Cancer Cell Lines“. International Journal of Molecular Sciences 20, Nr. 13 (28.06.2019): 3173. http://dx.doi.org/10.3390/ijms20133173.
Der volle Inhalt der QuelleNio, Kouki, Taro Yamashita und Shuichi Kaneko. „Chromodomain-helicase-DNA-binding protein 4: a novel therapeutic target in liver cancer stem cells“. Chinese Clinical Oncology 6, Nr. 1 (Februar 2017): 12. http://dx.doi.org/10.21037/cco.2016.07.01.
Der volle Inhalt der QuelleWong, Sze Chuen Cesar, Moon Tong Cheung, Lewis Lai Yin Luk, Vivian Ha Man Lee, Pak Tat Chan, Hin Fung Andy Tsang, Evelyn Yin Kwan Wong, Vivian Weiwen Xue, Amanda Kit Ching Chan und John Kwok Cheung Chan. „Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients“. Oncotarget 9, Nr. 6 (19.12.2017): 6737–51. http://dx.doi.org/10.18632/oncotarget.23424.
Der volle Inhalt der QuelleBagi, Zoltán, Katalin Balog, Bianka Tóth, Milán Fehér, Péter Bársony, Edina Baranyai, Sándor Harangi et al. „Genes and elements involved in the regulation of the nervous system and growth affect the development of spinal deformity in Cyprinus carpio“. PLOS ONE 17, Nr. 4 (08.04.2022): e0266447. http://dx.doi.org/10.1371/journal.pone.0266447.
Der volle Inhalt der QuelleNovillo, Apolonia, Ana Fernández-Santander, Maria Gaibar, Miguel Galán, Alicia Romero-Lorca, Fadoua El Abdellaoui-Soussi und Pablo Gómez-del Arco. „Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer“. Frontiers in Oncology 11 (26.04.2021). http://dx.doi.org/10.3389/fonc.2021.633233.
Der volle Inhalt der QuelleHelness, Anne, Jennifer Fraszczak, Charles Joly-Beauparlant, Halil Bagci, Christian Trahan, Kaifee Arman, Peiman Shooshtarizadeh et al. „GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors“. Communications Biology 4, Nr. 1 (Dezember 2021). http://dx.doi.org/10.1038/s42003-021-02889-2.
Der volle Inhalt der QuelleLi, Pengyu, Jielin Tang, Zhixin Yu, Cheng Jin, Zhipeng Wang, Mengzhen Li, Dingfeng Zou et al. „CHD4 acts as a critical regulator in the survival of spermatogonial stem cells in mice“. Biology of Reproduction, 18.08.2022. http://dx.doi.org/10.1093/biolre/ioac162.
Der volle Inhalt der QuelleGeyer, Fabian, Maximilian Geyer, Ute Reuning, Sarah Klapproth, Klaus-Dietrich Wolff und Markus Nieberler. „CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC“. Scientific Reports 14, Nr. 1 (09.04.2024). http://dx.doi.org/10.1038/s41598-024-58958-z.
Der volle Inhalt der QuelleShi, Wei, Angel P. Scialdone, James I. Emerson, Liu Mei, Lauren K. Wasson, Haley A. Davies, Christine E. Seidman, Jonathan G. Seidman, Jeanette G. Cook und Frank L. Conlon. „Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1“. Circulation Research, 31.05.2023. http://dx.doi.org/10.1161/circresaha.122.322223.
Der volle Inhalt der QuelleWu, Meng-Ling, Kate Wheeler, Robert Silasi, Florea Lupu und Courtney T. Griffin. „Endothelial Chromatin-Remodeling Enzymes Regulate the Production of Critical ECM Components During Murine Lung Development“. Arteriosclerosis, Thrombosis, and Vascular Biology, 13.06.2024. http://dx.doi.org/10.1161/atvbaha.124.320881.
Der volle Inhalt der QuelleSchilders, Kim A. A., Gabriëla G. Edel, Evelien Eenjes, Bianca Oresta, Judith Birkhoff, Anne Boerema-de Munck, Marjon Buscop-van Kempen et al. „Identification of SOX2 Interacting Proteins in the Developing Mouse Lung With Potential Implications for Congenital Diaphragmatic Hernia“. Frontiers in Pediatrics 10 (09.05.2022). http://dx.doi.org/10.3389/fped.2022.881287.
Der volle Inhalt der QuellePinal-Fernandez, Iago, Jose Cesar Milisenda, Katherine Pak, Sandra Muñoz-Braceras, Maria Casal-Dominguez, Jiram Torres-Ruiz, Stefania Dell'Orso et al. „Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies“. Annals of the Rheumatic Diseases, 02.05.2023, ard—2023–223873. http://dx.doi.org/10.1136/ard-2023-223873.
Der volle Inhalt der QuelleXiao, Guodong, Weiping Lu, Jing Yuan, Zuyue Liu, Peili Wang und Huijie Fan. „Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition“. Journal of Translational Medicine 22, Nr. 1 (24.01.2024). http://dx.doi.org/10.1186/s12967-024-04897-2.
Der volle Inhalt der QuelleYao, Hui, Douglas F. Hannum, Yiwen Zhai, Sophie F. Hill, Ricardo D. ’Oliveira Albanus, Wenjia Lou, Jennifer M. Skidmore et al. „CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression“. Scientific Reports 10, Nr. 1 (15.10.2020). http://dx.doi.org/10.1038/s41598-020-74537-4.
Der volle Inhalt der QuelleZhang, Zhen, Flávia C. Costa, Ee Phie Tan, Nathan Bushue, Catherine E. Costello, Mark E. McComb, Stephen A. Whelan, Kenneth R. Peterson und Chad Slawson. „O‐GlcNAc Transferase and O‐GlcNAcase Interact with Mi2β at the Aγ‐Globin Promoter“. FASEB Journal 30, S1 (April 2016). http://dx.doi.org/10.1096/fasebj.30.1_supplement.803.3.
Der volle Inhalt der QuelleXu, Weiwei, Weibin Zhou, Haiyang Lin, Dan Ye, Guoping Chen, Fengqin Dong und Jianguo Shen. „A novel heterozygous mutation of CHD7 gene in a Chinese patient with Kallmann syndrome: a case report“. BMC Endocrine Disorders 21, Nr. 1 (25.09.2021). http://dx.doi.org/10.1186/s12902-021-00836-0.
Der volle Inhalt der QuelleLaureano, Alejandra, Jihyun Kim, Edward Martinez und Kelvin Y. Kwan. „Chromodomain Helicase DNA Binding Protein 4 in Cell Fate Decisions“. Hearing Research, Mai 2023, 108813. http://dx.doi.org/10.1016/j.heares.2023.108813.
Der volle Inhalt der QuelleMuhammad, Tahir, Stephen F. Pastore, Katrina Good, Juan Ausió und John B. Vincent. „Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders“. Psychiatric Genetics, 16.10.2023. http://dx.doi.org/10.1097/ypg.0000000000000353.
Der volle Inhalt der QuelleCoassolo, Sébastien, Guillaume Davidson, Luc Negroni, Giovanni Gambi, Sylvain Daujat, Christophe Romier und Irwin Davidson. „Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation“. Nature Communications 12, Nr. 1 (19.03.2021). http://dx.doi.org/10.1038/s41467-021-21960-4.
Der volle Inhalt der QuelleD’Incal, Claudio Peter, Kirsten Esther Van Rossem, Kevin De Man, Anthony Konings, Anke Van Dijck, Ludovico Rizzuti, Alessandro Vitriolo et al. „Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism“. Clinical Epigenetics 15, Nr. 1 (21.03.2023). http://dx.doi.org/10.1186/s13148-023-01450-8.
Der volle Inhalt der QuelleJiang, Dongfang, Tingting Li, Caixia Guo, Tie-Shan Tang und Hongmei Liu. „Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration“. Cell & Bioscience 13, Nr. 1 (16.01.2023). http://dx.doi.org/10.1186/s13578-023-00953-4.
Der volle Inhalt der QuelleSchulz, Vanessa E., Jeffrey F. Tuff, Riley H. Tough, Lara Lewis, Benjamin Chimukangara, Nigel Garrett, Quarraisha Abdool Karim et al. „Host genetic variation at a locus near CHD1L impacts HIV sequence diversity in a South African population“. Journal of Virology, 25.09.2023. http://dx.doi.org/10.1128/jvi.00954-23.
Der volle Inhalt der Quelle